Diebold Nixdorf, Incorporated (DBD)
(Delayed Data from NYSE)
$41.00 USD
0.00 (0.00%)
Updated May 10, 2024 04:00 PM ET
After-Market: $40.98 -0.02 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DBD 41.00 0.00(0.00%)
Will DBD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DBD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DBD
Are Computer and Technology Stocks Lagging Badger Meter (BMI) This Year?
What Makes Diebold Nixdorf, Incorporated (DBD) a Good Fit for 'Trend Investing'
DBD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Check Point (CHKP) Q1 Earnings & Sales Beat Expectations
SNAP Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Archrock and Diebold Nixdorf have been highlighted as Zacks Bull and Bear of the Day
Other News for DBD
Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
D.A. Davidson Keeps Their Buy Rating on Diebold Nixdorf Inc (DBD)
Wedbush upgrades Diebold with shares at '"extremely attractive levels'
Wedbush gets more bullish on Diebold, upgrades shares
Diebold Nixdorf Inc (DBD) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with ...